Overview
Kathy Theall is an Oncologist practicing medicine in Cambridge, Massachusetts.
Dr. Theall is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer, Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Infantile Neutropenia.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
300 Tech Sq Ste 302, Cambridge, MA 02139
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Kathy Theall
How do I make an appointment with Dr. Kathy Theall?
You can book an appointment with Dr. Kathy Theall by calling their office at 617-674-6566. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kathy Theall a top-rated expert for HER2 Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kathy Theall is classified as an Distinguished expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kathy Theall specialize in?
While Dr. Kathy Theall is a Oncology, they have specific expertise in HER2 Negative Breast Cancer, Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Kathy Theall participate in research or clinical trials?
Yes. Dr. Kathy Theall has published 10 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Dr. Kathy Theall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HER2 Negative Breast CancerDr. Theall isDistinguished. Learn about HER2 Negative Breast Cancer.
- Advanced
- Breast CancerDr. Theall isAdvanced. Learn about Breast Cancer.
- Experienced
- Infantile NeutropeniaDr. Theall isExperienced. Learn about Infantile Neutropenia.
- PIK3CA-Related Overgrowth SpectrumDr. Theall isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.